The development of a new Escherichia coli tester strain for use in metabolic and mechanistic studies of genotoxins, strain MR2101/pKRll, has recently been reported. This strain, a derivative of the E.coli K12 laboratory strain AB1157, has sensitivity towards the detection of basesubstitution mutagenesis, monitored by the reversion of arginine auxotrophy [argE3, (ochre)]. Besides arginine, MR2101/pKRll is auxotrophic for histidine (hisG4), leucine (leuB6), proline (AproA) and threonine (thr-1). MX100 was developed to overcome the auxotrophy for four amino acids of MR2101/pKRll which are non-essential for the mutagenic responsiveness of the strain. We restored the biosynthesis for these four amino acids in MR2101/pKRll, resulting in strain MX100. This strain showed an almost 2-fold increase in mutagenic activity relative to MR2101/ pKRll with a set of diagnostic mutagens (aflatoxin Bl, benzo[a]pyrene, 4-nitroquinoline-l-oxide, 2,7-dimethylbenz[a]anthracene and others) and was further characterized with other types of mutagens in which it showed sensitivity towards the detection of oxidative (H 2 O 2 , f-butylhydroperoxide, cumene-hydroperoxide, KO 2 ) and car bony 1 mutagens (methylglyoxal, malondialdehyde). As MX 100 seems to have the right characteristics of a versatile genotoxicity tester strain and due to the extensive genetic and physiological knowledge of E.coli K12 in general and AB1157 in particular, we propose that MX 100 could serve as mother strain for the development of specialized tester strains, of interest in studies of metabolism and/or mechanism of action of genotoxic carcinogens.
Introduction
We developed recently a new Escherichia coli K12 tester strain, MR2101/pKRl 1, for the study of genotoxic mechanisms and metabolism studies of chemicals (Kranendonk et ai, 1994a,b) in which our laboratory has been involved for a number of years (Rueff et ai, 1992a,b; Kranendonk et ai, 1993 , Rodrigues et ai, 1993 , 1994 Gaspar et ai, 1994) . The strain is defective in the lipopolysaccharide core (LPS d ), part of the outer membrane, but contains a partial deletion of uvrA, a component of DNA excision repair and a newly constructed mutator plasmid (pKRll), a derivative of pKMlOl, carrying the SOS-inducible mucAB system. The genetic target by which the chemical mutagenesis is assessed consists of a point mutation (ochre) in the arginine biosynthetic operon (argE3) which renders the bacterium unable to grow in the absence of arginine. The mutagenicity test is based on monitoring the back mutation to arginine independence which can occur via all possible transition and transversion base-substitutions (Todd et al, 1979) .
We report here on the development and characterization of an improved derivative of MR2101/pKRll, strain MX100. This new strain showed increased mutagenic responses relatively to MR2101/pKRll for a number of mutagens. The results presented here seem to characterize MX 100 as a versatile genotoxicity tester strain which can be applied in a plate assay as well as in a liquid-preincubation assay, and which shows sensitivity towards a variety of different classes of genotoxins, including oxidative and carbonyl mutagens. Based on these characteristics and the extensive genetic and physiological knowledge of E.coli K12 in general and AB1157 in particular, we propose that MX 100 could serve as the mother strain for the development of specialized tester strains, of particular interest in molecular studies of mechanisms and/or metabolism of genotoxic carcinogens.
Materials and methods
Reagents L-Histidine (L-his), r>glucose monohydrate, crystal violet, sodium azide (NaN 3 ), 2-nitrofluorene (2NF), malondialdehyde (MDA), H 2 O 2 and dimethyl sulphoxide (DMSO) were obtained from Merck (Darmstadt, Germany). The amino acids L-proline (L-pro), L-leucine (L-leu), L-threonine (L-thr) and Larginine (L-arg) as well as sodium deoxycholate, ethidium bromide, 7,12-dimethylbenz[a]anthracene (DMBA), pyrene, cumene-hydroperoxide (CHP), /-butyl-hydroperoxide (tBHP), methylglyoxal (MG), quercetin (Q), mitomycin C (MMC), potassium superoxide (KO 2 ) and 4-nitroquinoline-l-oxide (4NQO) were purchased from Sigma (St Louis, MO, USA). Ampicilhn (sodium salt) and tetracycline-HCI were from Northumbria Biologicals (Northumberland, UK). Bacto agar, bacto trypton, bacto yeast extract and bacto MacConkey agar were from Difco (Detroit, MI, USA); nutrient broth (NB) (Fluka, Buchs, Switzerland), thiamine (diphosphate form: triphosphoneurina) (Biofranco, Lisbon, Portugal) and aflatoxin Bl (AFB1) were from Aldnch (Madrid, Spain). The antibiotic kanamycin sulfate was obtained from BoehringerMannheim (Mannheim, Germany). Benzo[a]pyrene (B[a]P) was a gift from Pasteur Institute (Paris). Mutagens were dissolved in DMSO, except for CHP, MG, H 2 O2, KO 2 and NaN 3 , which were dissolved in water.
Strains and microbiological media
All microbiological media were as described previously (Kranendonk et ai, 1994a) . P| vlr transductions and isolation of lipopolysaccharide-defective (LPS d ) mutants were performed as described previously (Kranendonk el ai, 1994a) . The genotype and the origin of the different strains are shown in Table I .
Mutagenicity assays
Plate-incorporation assay. The mutagenicity plate-incorporation assays with MR210l/pKRI I and TA100 were performed as previously described (Kranendonk et ai, 1994a; Maron and Ames, 1983 respectively) . MXI0O was applied accordingly, without the addition of the four amino acids L-his, L-leu, L-pro and L-thr to the tester plates, unless otherwise stated Liquid-preincubation assay. The mutagenicity assays with the mutagens H2O2, CHP, KO 2 , tBHP, MG and MDA were performed in a liquid-prcincubation assay with strains TAI02 and TA104, as described by Maron and Ames (1983) with minor modifications (Abu-Shakra and Zeiger, 1990) . MX100 was employed in the same way using 1-2X10* stationary phase cells.
At least three independent determinations were carried out for each dose level. Mutagenic activities were determined from the slope as the least-squares line of the linear portion of the dose-response curve. thr-1, ara-14, leuB6, A(gpt-pmA) 62, lacYl, qsr, supE44, galK2, X', rfbDI, rpsUl, kdgKSI, 
Results

Development of strain MX100
The E.coli K12 strain MR2101/pKRll, a derivative of the laboratory strain AB1157 (see Table I ), seems to have the necessary characteristics of a genotoxicity tester strain, developed especially for mechanistic and metabolic studies of mutagens (Kranendonk et al., 1994a,b) . Besides the arginine auxotrophy, due to the argE3 mutation which constitutes the genetic target, it is auxotrophic for histidine [hisGA (ochre)], leucine (leuBS), proline (AproA) and threonine [thr-l (amber)], which is the origin of the impractical addition (in excess) of these four amino acids to the tester plates. We decided to restore the biosynthesis capacity of these four amino acids by four subsequent P,™ transactions using an appropriate donor strain to remedy the four afflicted genes in MR2101/pKRll. The arginine reversion by which mutagenicity is assessed can occur via (i) structural reversion of the argE3 (ochre) mutation to a sense codon or conversion to an amber codon which can be suppressed by the supE44 mutation; (ii) ochre suppressor formation de novo; or (iii) suppressor conversion of supE44 to supB (Todd et al, 1979) . These mutations cover all possible transitions and transversion base-substitutions. The donor strain [MM249 (supE44); see Table I ] was chosen carefully so that no interfering mutations would be introduced. In this way all the elements of the genetic target were maintained and the prototrophy for the four amino acids was in principle restored by the introduction of the wild-type form of the four afflicted genes but not by the introduction of a new suppressor mutation. The only way proline prototrophy could be restored was by introduction of the wild-type gene of proA as this gene is deleted in MR2101/pKRll. The four P1[MM294] transductions were carried out with the LPS + predecessor of strain MR2101 (MR2100; see Table I ) as LPS 5 bacteria are (partially) resistant to P, infection (Austin et al, 1990; Parker et al, 1992) . A stable LPS d mutant was isolated (FP401) with high permeability towards bulky compounds, which was similar to the one found for MR2101 (data not shown). Subsequently our mutator plasmid pKRl 1 (Kranendonk et al, 1994a) carrying the mucAB operon was introduced, resulting in strain MX 100.
Mutagenicity testing with MX100
Before employing MX 100 in mutagenicity assays, monitoring the arginine reversion, the optimum trace amount of arginine was verified, as determined before for MR2101/pKRU, to allow a limiting number of DNA replications of the tester bacteria in the presence of the test compound. This growth leads to a more accessible DNA target and allows the processing of the DNA lesion into a mutation (genetic fixation) (Mohn et al, 1984) . The optimal L-arg concentration (1 (ig/ml) was found to be equal to that found for MR2101/pKRU (Kranendonk et al, 1994a) . In these optimal conditions 205 revertants were picked up arbitrarily from different tester plates induced by different test compounds (see below) and checked for their true Arg + character. All 205 revertants maintained their Arg + character on subculture. A set of diagnostic compounds [as used by Kranendonk et al. (1994a) ] was tested with MX 100 and compared with MR2101/pKRll (see Table  II ). Almost all mutagens showed an increase in mutagenic activity (in revertants/nmol) with MX100 relative to MR2101/ pKRll, except for sodium azide [false positive of TA100 (McCann et al, 1975) ] and pyrene, which both remained negative. On average, the mutagenic response of MX 100 was increased almost 2-fold relative to MR2101/pKRll (1.70 ± 0.01, r = 0.999) for the compounds tested (see Figure 1) . As the LPS d mutations of MX100 and MR2101/pKRll were isolated independently, the increase in responsiveness could be due to differences in the ease of penetration of the test compounds. This hypothesis is excluded as both strains showed similar permeabilities of the LPS core. The composition of the tester plate of the two E.coli strains differ as the four amino acids could be omitted from the MX 100 tester plates. To verify whether the four amino acids could influence the magnitude of the mutagenic response, the mutagenic activity of 4NQO was determined in MR2101/pKRll and MX100 with and without the four amino acids present in the tester Escfaericfaia coli strain MXlOO plates, as for MR2101/pKRll (see Figure 2) . The mutagenic response of MX 100 for 4NQO in the presence of the amino acids regressed to the level of that found for MR2101/pKRll. We have found this effect for other mutagens (data not shown). The presence of the amino acids seem to diminish the mutagenic responsiveness of MX100 and it seems that, because they could be omitted from the minimal tester medium, the mutagenic response of MX100 is improved.
Further characterization of MX 100
We extended the number of test compounds to further characterize MX 100 and to verify the sensitivity of the arginine target towards other classes of mutagens. Our laboratory is involved in studies of oxidative mutagenesis (Almeida et al, 1992; Crist6vao et al, 1992; Rueff et al, 1992a Rueff et al, , 1993 Gaspar et al, 1994 ). MX100 was therefore tested with H 2 O 2 , CHP, tBHP and KO 2 , to determine the usefulness of MX 100 for such studies, and was compared with strain TA102, which together with strain TA104 was originally developed for the detection of oxidative mutagens (Levin et al, 1982 ) (see Table ID ). The mutagenic responses of these compounds were determined in a liquid-preincubation assay in which oxidative mutagens seem to be more readily detected (Abu-Shakra and Zeiger, 1990). The results show that MX 100 is sensitive towards the detection of this class of mutagen, and can be employed effectively in a liquid-preincubation assay. Moreover, MX 100 has a stable low background reversion (in spontaneous revertants) in contrast to the two Salmonella strains, which forms a major practical drawback, especially for TA102 (Jung et al, 1992) . The genetic target in TA102 and TA104 is constituted by the hisG42S (ochre) mutation, which is located plasmid-bome in TA102 and genomically in TA104. Furthermore, TA104 is hampered in DNA excision repair (uvrB), in contrast to TA102 (uvr + ). The His reversion of these strains seems to occur preferentially at the hisG site rather than ochre suppressor mutations outside the his operon (Levin et al, 1982) . The target is therefore constituted only by A:T base pairs which are equally present in the argE3 (ochre) mutation of MX100, forming indicators for the observed sensitivity of MX100 for oxidative mutagens. This is in concordance with the sensitivity of the Trp + reversion in the E.coli tester strain WP2 containing the trpE (ochre) mutation towards the detection of oxidative mutagens (Wilcox et al, 1990) . MX100 is more closely related to TA104 than to TA102, as both are excision repair deficient and contain both genomic (ochre) targets (see Table I ). TA104 has been shown to be sensitive towards the detection of carbonyl mutagens which apparently have an oxidative component in their mutagenic action (Mamett et al, 1985; Ueno et al, 1991) . MX100 was therefore subsequently tested with two carbonyl mutagens [methylglyoxal (MG) and malondialdehyde (MDA)], in comparison with TA104 (see Table HI ). TA102 and TA104 differ in their sensitivity towards the detection of DNA cross-linking agents which require an active excision repair for mutagenic activity (Levin et al, 1982) . This is confirmed by the results obtained with the DNA crosslinker mitomycin C (MMC) in the strains TA102, TA104 and MX100 (see Table IE ). The results obtained with the last three compounds seem to confirm the structural similarities between MX100 and TA104 and therefore the abilities of MX100 to detect oxidative mutagens.
Discussion
We have described here the development and characterization of MX100, an improved derivative of MR2101/pKRll. MX100 Results are shown as means representing at least three independent determinations for each dose-level ± SD.
was developed to overcome the auxotrophy of MR2101/pKRl 1 for four amino acids which are non-essential for the mutagenic responsiveness of the strain. The biosynthesis of these amino acids was restored in such a way that in principle no undesired genetic alterations were introduced which could interfere with the different ways of the arginine back mutation, as the hisGA, leuB6 and thr-l mutations can be suppressed by specific suppressor mutations (Todd et ai, 1979) . Such mutations could 'Mutagenicity: (+), mutagenic; (-), non-mutagenic.
•"References: 1, Brusick et al. (1980) ; 2, Kranendonk et al. (1994); 3, this paper, 4, Dyrby and Ingvardsen (1983); 5, Wilcox et al. (1990) .
have nullified part of the (multiple) arginine target which would have led to a decrease in mutagenic responsiveness. As the opposite was found, it is concluded that the restored biosynthesis pathways in MXlOO are due to the substitution of the afflicted genes. MXlOO showed an almost 2-fold increase in specific mutagenic activity with a set of diagnostic compounds relative to MR2101/pKRll. The compositions of the tester plate of the two E.coli strains differ as the four amino acids could be omitted from the MXlOO tester plates. We showed that it is probably because of this omission that MXlOO seems to be improved. It is tempting to speculate that amino acid starvation of MXlOO relative to MR2101/pKRll could, in a way similar to glucose starvation (Kopsidas and MacPhee, 1993) , diminish the efficiency of error-free repair with a parallel augmented error-prone repair, explaining the observed increase in mutagenic activity for MXlOO.
We showed here that the back mutation can also be induced by known oxidative and carbonyl mutagens. The results obtained for MXlOO with the wide spectrum of different mutagens reflects the different ways by which the arginine auxotrophy can revert, covering all possible transitions and transversions. This indicates the versatility of the arginine back mutation as the genetic target in MXlOO and seems to characterize MXlOO as a tester strain which can be of interest in studies of the mode of action of mutagens with multiple genotoxic effects. Table IV shows a comparison of mutagenicity results obtained in MXlOO versus routinely used tester strains, namely E.coli WP2 and Salmonella strains, demonstrating that the responses of MXlOO match the ones found in the other tester strains. MXlOO could, however, have some advantages over the routinely used tester strains in mechanistic and metabolic studies of genotoxins because MXlOO is derived from the E.coli K12 laboratory strain AB1157, a strain which is genetically very well characterized for DNA repair, especially for SOS mutagenesis (Langer et al., 1981 (Langer et al., , 1985 Sedgwick and Goodwin, 1985; Donnelly and Walker 1989, 1992; Sedgwick et al., 1991; Sommer et al., 1993) . Moreover, AB1157 has been shown to be one of the more mutable E.coli strains (Sedgwick et al., 1991) .
The loci of genes whose products could be involved in metabolism of genotoxins are in general best characterized in E.coli K12 relative to other prokaryotes (Mohn et al, 1984; Kranendonk et al, 1994a) . This can be beneficial in studies of the involvement of bacterial metabolism in the mutagenic effect of genotoxins. Escherichia coli is an attractive organism for studies of the involvement of the different repair mechan-isms in mutagenesis, as these mechanisms occur in E.coli via basic molecular processes which have their counterparts in higher, though much more complex, cells (Walker, 1985; Sancar and Sancar, 1988) , such as recombinational repair (Kowalczykowski et al, 1994) , excision repair (Barnes et al, 1993) and mismatch repair (Lindahl, 1994) . This last mentioned repair has been in focus recently, demonstrating the importance of mutagenesis studies in E.coli and the application of strain AB1157, due to the characterization of a locus in the human genome, coding for human MSH2, a homologue of E.coli Mut S and yeast MSH, the mutation of which is associated with hereditary non-polyposis colon cancer (HNPCC) (Fishel et al, 1993) . The expression of human MSH2 in E.coli (AB1157) demonstrated a physiological activity in E.coli mismatch repair (Fishel et al, 1993) .
It is due to the above described characteristics of E.coli in general and AB1157 and MXlOO in particular that we propose here that MXlOO could serve as the mother strain for the development of specialized tester strains, of interest in studies of metabolism and/or the mechanism of action of genotoxic carcinogens. These can be: (i) introduction of specific genetic targets (either genomic or plasmid-borne) by which the preferences of mutations induced by specific genotoxins can be studied; (ii) inactivation or overexpression of genes whose products are involved in specific DNA repair mechanisms, by which the involvement of specific DNA repair processes in the induction of specific mutations can be determined; (iii) inactivation or overexpression of specific bacterial genes whose products could be involved in the bio(in)activation of pregenotoxins; and (iv) expression of specific mammalian metabolizing enzymes. The latter is especially of interest because in the last few years much effort has been put into the unravelling of human metabolic pathways, involved in bio(in)-activation of genotoxins. One of the more promising approaches is the direct introduction of genes/cDNAs of mammalian metabolizing enzymes in the genotoxicity assay target cell (Gonzalez et al, 1991; Rodrigues et al, 1993) . Escherichia coli seems to be particularly appropriate for this application (Kranendonk et al, 1994b) . At the moment, MXlOO is being applied in all four mentioned areas.
